Commonwealth of Pennsylvania Public School Employees Retirement System’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.2M | Buy |
25,427
+1,594
| +7% | +$200K | 0.02% | 597 |
|
|
2025
Q1 | $2.64M | Buy |
23,833
+1,472
| +7% | +$163K | 0.02% | 633 |
|
|
2024
Q4 | $3.05M | Buy |
22,361
+103
| +0.5% | +$14.1K | 0.02% | 576 |
|
|
2024
Q3 | $2.56M | Sell |
22,258
-48
| -0.2% | -$5.53K | 0.02% | 621 |
|
|
2024
Q2 | $3.07M | Buy |
22,306
+294
| +1% | +$40.5K | 0.02% | 524 |
|
|
2024
Q1 | $3.04M | Buy |
22,012
+332
| +2% | +$45.8K | 0.02% | 539 |
|
|
2023
Q4 | $2.86M | Buy |
21,680
+1,905
| +10% | +$251K | 0.02% | 522 |
|
|
2023
Q3 | $2.22M | Sell |
19,775
-27,392
| -58% | -$3.08M | 0.02% | 570 |
|
|
2023
Q2 | $4.45M | Buy |
47,167
+3,663
| +8% | +$345K | 0.03% | 421 |
|
|
2023
Q1 | $4.4M | Buy |
43,504
+257
| +0.6% | +$26K | 0.04% | 380 |
|
|
2022
Q4 | $5.17M | Buy |
43,247
+5,328
| +14% | +$636K | 0.04% | 315 |
|
|
2022
Q3 | $4.03M | Buy |
37,919
+82
| +0.2% | +$8.71K | 0.04% | 329 |
|
|
2022
Q2 | $3.69M | Buy |
37,837
+3,069
| +9% | +$299K | 0.04% | 371 |
|
|
2022
Q1 | $3.26M | Buy |
34,768
+3,315
| +11% | +$311K | 0.03% | 480 |
|
|
2021
Q4 | $2.68M | Buy |
31,453
+185
| +0.6% | +$15.8K | 0.03% | 590 |
|
|
2021
Q3 | $3M | Sell |
31,268
-229
| -0.7% | -$22K | 0.03% | 465 |
|
|
2021
Q2 | $3.07M | Buy |
31,497
+156
| +0.5% | +$15.2K | 0.03% | 485 |
|
|
2021
Q1 | $3.05M | Buy |
+31,341
| New | +$3.05M | 0.04% | 457 |
|
|
2013
Q3 | – | Sell |
-22,085
| Closed | -$295K | – | 1354 |
|
|
2013
Q2 | $295K | Buy |
+22,085
| New | +$295K | 0.01% | 1213 |
|